Cargando…
COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994343/ https://www.ncbi.nlm.nih.gov/pubmed/33777973 http://dx.doi.org/10.3389/fmed.2021.620175 |
| _version_ | 1783669736189460480 |
|---|---|
| author | Clark, Nicole F. Taylor-Robinson, Andrew W. |
| author_facet | Clark, Nicole F. Taylor-Robinson, Andrew W. |
| author_sort | Clark, Nicole F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7994343 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79943432021-03-27 COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? Clark, Nicole F. Taylor-Robinson, Andrew W. Front Med (Lausanne) Medicine Frontiers Media S.A. 2021-03-12 /pmc/articles/PMC7994343/ /pubmed/33777973 http://dx.doi.org/10.3389/fmed.2021.620175 Text en Copyright © 2021 Clark and Taylor-Robinson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Clark, Nicole F. Taylor-Robinson, Andrew W. COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title_full | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title_fullStr | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title_full_unstemmed | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title_short | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
| title_sort | covid-19 therapy: could a copper derivative of chlorophyll a be used to treat lymphopenia associated with severe symptoms of sars-cov-2 infection? |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994343/ https://www.ncbi.nlm.nih.gov/pubmed/33777973 http://dx.doi.org/10.3389/fmed.2021.620175 |
| work_keys_str_mv | AT clarknicolef covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection AT taylorrobinsonandreww covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection |